Description
The session will focus on presenting the main inflammatory cardiomyopathies subtypes (Myocarditis; Sarcoidosis; DSP-Cardiomyopathy) and the arrhythmic risk, the risk stratifying strategies, and the currently therapies available (pharmacological and invasive) for each one of these substrates.
Learning Objectives
- Outline the importance of cardiac inflammation as a cause of cardiac arrhythmias across a wide spectrum of inherited and acquired cardiac conditions.
- Review the differences in arrhythmic risk stratification and ICD implantation practices required for common subgroups of inflammatory cardiomyopathies.
- Summarize data on VT ablation and cutting edge therapies modulating the arrhythmic risk for inflammatory cardiomyopathy.
Session Chair(s)
Alessio Gasperetti, MD, PhD
Jordana Kron, MD
Presentation
Myocarditis, Inflammation, and Arrhythmias
Presenter(s): Giovanni Peretto, MD, PhD
Sarcoidosis, Inflammation, and Arrhythmias
Presenter(s): Jonathan Chrispin, MD
Desmoplakin Cardiomyopathy, Inflammation, and Arrhythmias
Presenter(s): Cynthia A. James, PhD, CGC
Inflammatory Cardiomyopathy and VT Ablation
Presenter(s): Pasquale Santangeli, MD, PhD
Sport, Arrhythmia and Inflammatory Cardiomyopathy
Presenter(s): Rachel Lampert, MD
Disclosures
Giovanni Peretto:
- Abbott (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Jonathan Chrispin:
- Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
- Abbott Medical (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
- Boston Scientific (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Cynthia James:
- Lexeo, Inc. (Research (Contracted Grants for PIs and Named Investigators only) - Research)
- Pfizer, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
- StrideBio (Research (Contracted Grants for PIs and Named Investigators only) - Research)
- ARVADA Therapeutics (Research (Contracted Grants for PIs and Named Investigators only) - Research)
Pasquale Santangeli:
- Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
- Abbott (Honoraria/Speaking/Consulting Fee - Consulting)
- Medtronic (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
- Biotronik (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
- Boston Scientific (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Rachel Lampert:
- Nothing Relevant to Disclose
To view all Heart Rhythm 2025 Faculty Disclosures, please click
here.
Education Framework
Ventricular Tachyarrhythmias
-- Ventricular Fibrillation (VF) and SCA/SCD
-- 213. Know treatment strategies for protecting from and preventing recurrent ventricular fibrillation depending on the underlying etiology.
Other Arrhythmia Syndromes
-- Arrhythmogenic Cardiomyopathies
-- 269. Know the broad spectrum of genetic, systemic, infectious, and inflammatory disorders that make up the arrhythmogenic cardiomyopathies, including hypertrophic cardiomyopathy, arrhythmogenic right/left ventricular cardiomyopathy, cardiac amyloidosis, sarcoidosis, Chagas Disease, left ventricular noncompaction and muscular dystrophies.
Other Arrhythmia Syndromes
-- Arrhythmogenic Cardiomyopathies
-- 277. Know the methods to manage patients with arrhythmogenic cardiomyopathies, including the pharmacotherapy, ablation, lifestyle modifications and device therapy.